• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for Ceprotin

Ceprotin

OMRF receives top award from Oklahoma Venture Forum

May 19, 2022

Nonprofit foundation lauded for economic impact in Oklahoma

Filed Under: News Tagged With: Adakveo, andy weyrich, Ceprotin, Dr. Andrew S. Weyrich, Oklahoma Venture Forum, OVF, Soliris

Making A Mark

A patent provides its owner with an exclusive right to a new invention. And beginning in the 1990s, the U.S. Patent and Trademark Office granted a multitude to OMRF, sometimes more than a dozen in a single year. Only a decade earlier did Congress give OMRF and others the right to patent inventions that stemmed […]

OMRF researcher receives American Heart Association award

December 30, 2014

OMRF’s Charles Esmon was recognized by the AHA as a distinguished scientist.

Filed Under: News Tagged With: accolade, aha, american heart association, award, Ceprotin, Charles, charles esmon, chicago, coagulation biology, distinguished scientist, donor, Esmon, heart disease, honor, institute, lifetime achievement, llyod noble chair, medicine, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, ou, professor, research, science, scientist-news

Teaching an old drug new tricks

March 25, 2008

When Dr. Charles Esmon began studying activated protein C in the 1970s, he never imagined his work would lead to a pair of life-saving drugs. “Back then, we didn’t even know what activated protein C did in the body,” said the Oklahoma Medical Research Foundation scientist. “Our goal was to figure it out.” Figure it […]

Filed Under: News Tagged With: Ceprotin, Charles, Esmon, protein C, scientist-news, sepsis, Xigris

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace